These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19342637)

  • 1. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response.
    Tang J; Zhou R; Luger D; Zhu W; Silver PB; Grajewski RS; Su SB; Chan CC; Adorini L; Caspi RR
    J Immunol; 2009 Apr; 182(8):4624-32. PubMed ID: 19342637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.
    Luger D; Silver PB; Tang J; Cua D; Chen Z; Iwakura Y; Bowman EP; Sgambellone NM; Chan CC; Caspi RR
    J Exp Med; 2008 Apr; 205(4):799-810. PubMed ID: 18391061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
    Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
    Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells.
    Palmer MT; Lee YK; Maynard CL; Oliver JR; Bikle DD; Jetten AM; Weaver CT
    J Biol Chem; 2011 Jan; 286(2):997-1004. PubMed ID: 21047796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th17 cells: a new fate for differentiating helper T cells.
    Chen Z; O'Shea JJ
    Immunol Res; 2008; 41(2):87-102. PubMed ID: 18172584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.
    Tarrant TK; Silver PB; Wahlsten JL; Rizzo LV; Chan CC; Wiggert B; Caspi RR
    J Exp Med; 1999 Jan; 189(2):219-30. PubMed ID: 9892605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
    Keino H; Watanabe T; Sato Y; Okada AA
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionally distinct IFN-γ
    Chen YH; Eskandarpour M; Gondrand A; Zhang X; Gu R; Galatowicz G; Lightman SL; Calder VL
    Eur J Immunol; 2020 Dec; 50(12):1941-1951. PubMed ID: 32652562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells.
    Kimura A; Naka T; Kishimoto T
    Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12099-104. PubMed ID: 17623780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of Th17 differentiation by epidermal fatty acid-binding protein.
    Li B; Reynolds JM; Stout RD; Bernlohr DA; Suttles J
    J Immunol; 2009 Jun; 182(12):7625-33. PubMed ID: 19494286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tofacitinib inhibits the development of experimental autoimmune uveitis and reduces the proportions of Th1 but not of Th17 cells.
    Bing SJ; Lyu C; Xu B; Wandu WS; Hinshaw SJ; Furumoto Y; Caspi RR; Gadina M; Gery I
    Mol Vis; 2020; 26():641-651. PubMed ID: 33088168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses.
    Grajewski RS; Hansen AM; Agarwal RK; Kronenberg M; Sidobre S; Su SB; Silver PB; Tsuji M; Franck RW; Lawton AP; Chan CC; Caspi RR
    J Immunol; 2008 Oct; 181(7):4791-7. PubMed ID: 18802082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
    Sonderegger I; Kisielow J; Meier R; King C; Kopf M
    Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis.
    Yoshimura T; Sonoda KH; Ohguro N; Ohsugi Y; Ishibashi T; Cua DJ; Kobayashi T; Yoshida H; Yoshimura A
    Rheumatology (Oxford); 2009 Apr; 48(4):347-54. PubMed ID: 19164426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant NKT cells inhibit development of the Th17 lineage.
    Mars LT; Araujo L; Kerschen P; Diem S; Bourgeois E; Van LP; Carrié N; Dy M; Liblau RS; Herbelin A
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6238-43. PubMed ID: 19325124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.